June 8, 2015 at 1:37 pm

MISSD at Naomi Ruth Cohen Institute Conference

Such great thought-provoking discussions yesterday at the Naomi Ruth Cohen Conference as we provided information and raised awareness about possible side effects of medications and shared our knowledge about akathisia with others. We had the wonderful opportunity to meet such amazing professionals who were eager to hear what we had to say and become involved in our organization!


May 22, 2015 at 12:24 pm


Are Some Military Suicides Medication-Induced?

The statistics are staggering: At least 1 in 5 service members in the military suffer from post-traumatic stress disorder, or PTSD. 300,000 are experiencing depression, brain trauma or PTSD. Twenty-two vets die by suicide every day. And since 2001, more military servicemen and women died by suicide than in combat in Afghanistan. Sobering numbers indeed, and many veterans make it out of the threatening and traumatic climates of war only to die by their own hands when they return to American soil.

This ABC news piece highlights the story of 29-year-old Sargeant Cole Van Dorn, a Chicago area native, whose father said took his life last month after struggling with PTSD and taking a “stew” or “soup” of medications. Medications used to treat military servicemen and women have doubled over the past decade, according to the segment. Dr. K. Laun Phan, a neuropsychiatric researcher at University of Chicago at Illinois and the US Department of Veterans Affairs, explains in the piece that there are few medications effective in treating PTSD. Cole Van Dorn’s father believes his son would still be alive if he had not been on the cocktail of medications, some of which his son was told he would have to take for the rest of his life.

TAPS (Tragedy Assistance Program for Survivors), is a not-for-profit for survivors and families of fallen heroes, and it provides a program for suicide survivors with resources for families. There are promising new treatments on the horizon for those with PTSD. Dr. Eugene Lipov of the Global Post Traumatic Stress Injury Foundation, based in Chicago, is pioneering the use of SGB, stellate ganglion block treatment, to treat acute symptoms of PTSD, and is targeting veterans due to the alarming rate of military suicides. Originally a treatment for pain, the mixture of saline, anesthetic and anti-inflammatory agents is injected into the cervical spine, and can provide relief and stabilization along with other healing modalities. Go to chicagomedicalinnovations.org to learn more.


April 15, 2015 at 2:03 pm

MISSD 2015 Fundraising Event

Please mark your calendars for the next MISSD event!


April 14, 2015 at 3:50 pm

Theodore Van Putten describes “The Many Faces of Akathisia” as early as 1975

Check out the article (PDF)

January 6, 2015 at 5:06 pm

National Center for Health Research: The Voice For Prevention, Treatment, and Policy

Wendy Dolin, (founder) was asked to participate in the June 2014 National Center For Health Research Conference in Washington, DC. The objective for this workshop (which was led by 10 patient and consumer advocates) is to learn about the scientific evidence perspectives that the FDA then considers when making decisions to approve or recall a medical product. Wendy Dolin was one of the participants on this panel.

Below are some excerpts from an article summarizing the conference, with MISSD founder Wendy Dolin featured in one of the photos:

Page 1 (PDF)

Page 2 (PDF)

Page 3 (PDF)

November 29, 2014 at 7:57 pm

New Bill Mandates Independent Review of Veterans’ Suicide-Prevention Programs

View the full article here.

October 22, 2014 at 9:35 pm

Chantix Video Presented At FDA Advisory Committee

Pfizer has recently presented Chantix to the FDA in efforts to remove the black box warning (although side effects of this drug are very serious and have lead to suicidal behavior). Chantix did NOT lose the black box warning, but here is a powerful video discussing some of the side effects of this drug.

September 29, 2014 at 4:13 pm

One Dose of Antidepressant Changes Brain Connections, Study Says

Small study investigates how brain cells react differently to SSRI’s.

“Experts said the hope is to eventually be able to predict which people with depression are likely to benefit from a drug — and which people would fare better with a different option.”

-Norton, A.; HealthDay News 9/18/2014

View the full article here.

August 13, 2014 at 3:00 pm

MISSD Supports Suicide Prevention at the 2014 Out of the Darkness Walk

September marks Suicide Awareness Month and the MISSD Team will once again be participating in the Out of the Darkness Chicago Walk, put on by the American Foundation for Suicide Prevention (AFSP)! The walk will take place at Grant Park on Saturday, September 20th, 2014!  We are looking forward to raising more awareness about our organization and supporting other suicide prevention related organizations.  For more information about this walk, you can visit http://afsp.donordrive.com/index.cfm?fuseaction=donorDrive.event&eventID=2579.

August 6, 2014 at 9:08 pm

MISSD Holds 2ND Annual Fundraising Event

September marks Suicide Awareness Month and The Medication-Induced Suicide Education Foundation in Memory of Stewart Dolin (MISSD) will hold its 2nd Annual Fundraising Event.

The event is on Thursday, September 4, 2014, from 6:30 pm- 9:30 pm, at Park West, 322 West Armitage Avenue, Chicago, Illinois. The evening will be educational, but fun-filled with appetizers, cocktails and raffles. Tickets are $50 (35 years and under) or $125 (36 years and over). To purchase tickets please go to missd.eventbrite.com.

Two years ago, MISSD was founded in Stewart Dolin’s memory to raise awareness and educate the public about the dangers of medication-induced suicide and akathisia.  MISSD is not an anti-drug organization, rather we look to raise awareness about potential side effects and better monitoring of patients who have recently started or stopped a medication, specifically a Selective Serotonin Reuptake Inhibitor (SSRI) medication.

MISSD has made many strides towards reaching these objectives by reaching out to the public by attending and participating in related conferences and walks, developing a brochure and more. We are in the midst of putting together an educational presentation to present at schools, hospitals, and other related venues.

To learn more about our organization, please visit www.missd.co.